{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:16:53Z","timestamp":1757704613578},"reference-count":17,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,2,7]],"date-time":"2006-02-07T00:00:00Z","timestamp":1139270400000},"content-version":"vor","delay-in-days":2869,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[1998,4]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> An established combination gene therapy strategy involving adenovirus vector delivery of the herpes thymidine kinase (tk) and murine interleukin\u20102 genes was adapted to treat salivary gland cancer in a murine model. Salivary tumors were generated by transcutaneous injection of 5 \u00d7 10<jats:sup>5<\/jats:sup> murine squamous carcinoma cells into the submandibular gland of syngeneic C3H\/HeJ mice. After one week, established submandibular gland tumors were injected with a recombinant adenovirus containing therapeutic and control genes. Animals were subsequently administered ganciclovir twice daily (25 mg\/kg) for six days. All animals receiving tk and ganciclovir demonstrated tumor regression, however a significantly greater response was seen in mice that were treated with both tk + mIL\u20102. Residual tumors from all treatment and control groups were harvested for microscopic evaluation and immunohistochemistry staining. Specific immunostaining revealed a predominance of CD8<jats:sup>+<\/jats:sup> lymphocytes in the tumor beds of the animals treated with IL\u20102, suggesting a preferential immune response resulting from the local IL\u20102 expression. Although still in its infancy, the concept of using adenoviral gene therapy strategies to provide less invasive means of treating salivary tumors is promising.<\/jats:p>","DOI":"10.1111\/j.1749-6632.1998.tb09644.x","type":"journal-article","created":{"date-parts":[[2006,2,7]],"date-time":"2006-02-07T09:39:45Z","timestamp":1139305185000},"page":"163-170","source":"Crossref","is-referenced-by-count":6,"title":["Combination Gene Therapy for Salivary Gland Cancer"],"prefix":"10.1111","volume":"842","author":[{"suffix":"JR.","given":"BERT W.","family":"O'MALLEY","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAQING","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,2,7]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"Kaplan M.J. & M.E. Johns. 1993. Salivary Glands: Malignant neoplasms.InOtolaryngology\u2010Head and Neck Surgery second edition. Mosby\u2010Year Book Inc. St. Louis Missouri."},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0030-6665(20)31712-6","article-title":"Malignant tumors of the major salivary glands","volume":"19","author":"Friedman M.","year":"1986","journal-title":"Otolaryngol. Clin. North. Am."},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90591-2"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.8.3539"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.4.1217"},{"key":"e_1_2_6_7_2","first-page":"5276","article-title":"Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy","volume":"46","author":"Moolten F.L.","year":"1986","journal-title":"Cancer. Res."},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/82.4.297"},{"key":"e_1_2_6_9_2","first-page":"1080","article-title":"Adenovirus\u2010mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model","volume":"55","author":"O'Malley B.W.","year":"1995","journal-title":"Cancer Res."},{"key":"e_1_2_6_10_2","first-page":"1737","article-title":"Combination gene therapy for oral cancer in a murine model","volume":"56","author":"O'Malley B.W.","year":"1996","journal-title":"Cancer Res."},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.8.3054"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1995.01890020059012"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1997.01900010022003"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.1.21"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.7.2577"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1993.4.6-725"},{"key":"e_1_2_6_17_2","first-page":"5274","article-title":"The \u201cbystander effect\u201d: Tumor regression when a fraction of the tumor mass is genetically modified","volume":"53","author":"Freeman S.M.","year":"1993","journal-title":"Cancer Res."},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/ssu.2980030405"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.1998.tb09644.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.1998.tb09644.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T10:13:10Z","timestamp":1695636790000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.1998.tb09644.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,4]]}},"alternative-id":["10.1111\/j.1749-6632.1998.tb09644.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.1998.tb09644.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,4]]}}}